Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trial Designs for Evaluating Migraine Treatment
NCT06617832Recruiting
- Sponsor
- Aarhus University
- Start
- Nov 2024
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of sumatriptan in episodic migraine (2 arms), sponsored by Aarhus University. Primary endpoints: Headache intensity at 2 hours and Adverse events at 2 hours. Started Nov 2024; status: recruiting.
02
Drugs
sumatriptan
03
Conditions
episodic migraine
Beyond the preview
Go deeper on NCT06617832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06617832.